webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide

  CAS No.: 1225588-22-6   Cat No.: BADC-00531 4.5  

N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide is a fluorinated aldehyde ADC linker designed for efficient bioorthogonal conjugation, providing enhanced stability and specificity in antibody-drug conjugate synthesis.

N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide

Structure of 1225588-22-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C16H14FNO3
Molecular Weight
287.29
Shipping
Room temperature

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
N-[2-(4-fluorophenoxy)ethyl]-4-formylbenzamide
Canonical SMILES
C1=CC(=CC=C1C=O)C(=O)NCCOC2=CC=C(C=C2)F
InChI
InChI=1S/C16H14FNO3/c17-14-5-7-15(8-6-14)21-10-9-18-16(20)13-3-1-12(11-19)2-4-13/h1-8,11H,9-10H2,(H,18,20)
InChIKey
HSTGQPQRMKBHPK-UHFFFAOYSA-N
Shipping
Room temperature

N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide is a chemical compound with promising applications in medicinal chemistry, particularly in the design and development of targeted therapies for cancer and other diseases. The structure of this molecule features a fluorophenoxyethyl group linked to a formylbenzamide, which plays a significant role in its bioactivity. The presence of a fluorine atom in the phenoxy group enhances the compound’s lipophilicity, which can improve its ability to cross cellular membranes and its overall bioavailability. This characteristic makes it a valuable candidate for the development of small molecule drugs.

One of the key applications of N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide is in cancer therapy. The compound's structure suggests it may interact with specific biological targets, including those involved in cancer cell proliferation and survival. It is hypothesized that the formyl group may facilitate binding to certain receptors or enzymes involved in the regulation of cancer cell growth. Additionally, the fluorophenoxyethyl side chain can increase the specificity of the compound toward certain tumor cells or tissues, improving its selective cytotoxicity while minimizing off-target effects. This makes it a potential candidate for development as an anticancer agent, especially in the treatment of solid tumors.

N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide may also have applications in the modulation of enzyme activity, particularly in relation to the inhibition of key enzymes involved in disease pathways. The formyl group and the fluorophenoxyethyl chain could interact with enzymes like kinases or proteases that are crucial for cell signaling and metabolic processes. By selectively inhibiting these enzymes, the compound could disrupt abnormal cellular functions, offering therapeutic potential in diseases characterized by dysregulated enzyme activity, such as cancer, autoimmune diseases, and inflammatory disorders. This property opens doors for its use as a scaffold for designing enzyme inhibitors.

Another promising application of this compound is in the development of molecular probes for research in drug discovery. The unique structure of N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide makes it a suitable candidate for use in studies exploring the mechanisms of action of small molecules in cellular systems. By attaching various reporter groups or fluorescent tags to the compound, researchers can use it to track the interaction of the drug with its target in real-time. This application could significantly aid in the optimization of drug candidates by providing insights into drug-receptor interactions and cellular uptake.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Gly-Gly-Gly-Gly-OH | Zilovertamab vedotin | Boc-Val-Cit-PABA | 4-Formyl-N-(2-Phenoxyethyl)benzamide | Lycorine hydrochloride | Bis-PEG2-NHS Ester | N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide | Fmoc-D-Val-D-Cit-PAB | Z-D-Dbu(N3)-OH | N-(2-(3-Fluorophenoxy)ethyl)-4-Formylbenzamide | N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide
Send Inquiry
Verification code
Inquiry Basket